Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
J Cardiothorac Surg ; 19(1): 456, 2024 Jul 17.
Article in English | MEDLINE | ID: mdl-39020363

ABSTRACT

BACKGROUND: The principles of chest drainage have not changed significantly since 1875 when Bülau introduced the idea of underwater drainage tube which became a trademark of thoracic surgery. We performed a prospective, randomized trial comparing omitting pleural drain (drainless group) versus drainage with small low suction drain (drainage group) strategies of thoracic surgery when the visceral pleura remains intact. Aiming to investigate whether these approaches represent safe treatment options. METHODS: A multi-center, prospective, parallel group, randomized, controlled trial enrolling patients after thoracic procedures in which visceral pleura remained intact at the end of surgery between August 2020 and September 2023. After completion of the procedure a suction-seal test was conducted on all patients. If suction-seal test was positive to confirm absence of air leak, patients were randomized to either receive low auto-suction drain as a solo pleural drain (drainage group) or not to receive drain (drainless group). RESULTS: During the study period, 111 patients were recruited. Eleven patients had negative Suction-seal test and were excluded by inserting a traditional underwater seal. The remaining 100 patients were randomly assigned to either drainage group with low suction drain (Fig. 1) (n = 50) or drainless group (n = 50). CONCLUSION: The results of this study suggest that either omitting drain or inserting a low auto suction drain safely substitutes the one-way valve when the visceral pleura remains intact. Omitting drain or inserting portable small caliber drain encourages early mobilization and is associated with shorter hospital stay.


Subject(s)
Drainage , Humans , Suction/methods , Suction/instrumentation , Male , Female , Prospective Studies , Drainage/instrumentation , Drainage/methods , Middle Aged , Aged , Chest Tubes , Treatment Outcome , Thoracic Surgical Procedures/methods
2.
Cureus ; 16(2): e54111, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38487158

ABSTRACT

Solitary fibrous tumors of the pleura (SFTPs) are rare and typically benign neoplasms with limited reported cases. Despite their initial characterization as a pleura-based lesion, these neoplasms can occur in various anatomical locations. These tumors can present with paraneoplastic syndromes and have potential malignant transformations. Herein, we report a case of a 47-year-old female presenting with chest pain, cough, and weakness who was subsequently diagnosed with a benign SFTP. The patient required surgical intervention and underwent a wedge resection via video-assisted thoracoscopic surgery. The patient's recovery was uneventful, demonstrating effective management.

3.
Cureus ; 16(2): e54542, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38516481

ABSTRACT

Microwave ablation (MWA) has become an increasingly used procedure for the management of lung nodules in recent years. Here, we report a 33-year-old female presenting with massive pulmonary necrosis and tension pneumothorax after MWA for metastatic colon cancer. She required surgical intervention, including thoracotomy, debridement, and wedge resection, for the management of these complications.

4.
In Vivo ; 37(1): 310-319, 2023.
Article in English | MEDLINE | ID: mdl-36593057

ABSTRACT

BACKGROUND/AIM: Lung transplantation is a life-saving procedure for patients with end-stage lung diseases. T-Cell receptor excision circle (TREC) is circular DNA produced during T-cell receptor gene rearrangement in the thymus and indicates naive T-cell migration from the thymus. Therefore, its levels represent thymic T-cell output. Post-transplant lymphocyte kinetics correlate with graft tolerance. The aim of this study was to investigate T-lymphocyte kinetics in the early recovery period after lung transplantation. For this purpose, copy numbers of TREC were determined in patients with a lung transplant. In addition, TREC copy numbers were evaluated according to age, diagnosis and the forced expiratory volume in 1 second (FEV1) of lung transplant patients. MATERIALS AND METHODS: Peripheral blood samples were taken from patients aged 23 to 59 years who underwent lung transplantation at the Thoracic Surgery Clinic, Kartal-Kosuyolu High Specialization Educational and Research Hospital. This study included peripheral blood samples from 11 lung transplant patients (comprising four with chronic obstructive pulmonary disease, three with idiopathic pulmonary fibrosis, one with cystic fibrosis, one with silicosis and two with bronchiectasis; three females in total). Samples were taken at three different timepoints: Before transplant, and 24 hours and 7 days post transplant. TREC copy numbers were analyzed with real time reverse transcriptase-polymerase chain reaction. RESULTS: Post-transplant TREC numbers and density values were higher compared to pre-transplant values, although these differences were statistically insignificant. TREC copy numbers were found to be significantly higher in patients younger than 45 years compared to patients older than 45 years. At 24 hours after the transplant, the average TREC copy number/peripheral blood mononuclear cells of the cases with an FEV1 value of or below 50% was found to be statistically significantly higher than that of cases with an FEV1 value above 50% (p=0.046). There was no statistically significant difference in TREC copy numbers between male and female patients or by diagnostic group. CONCLUSION: TREC copy numbers can be evaluated as a prognostic marker for lung transplantation. There is a need for multicenter studies with more patients.


Subject(s)
Lung Transplantation , T-Lymphocytes , Humans , Male , Female , Gene Rearrangement, T-Lymphocyte , Leukocytes, Mononuclear , DNA Copy Number Variations , Thymus Gland , Receptors, Antigen, T-Cell
5.
Turk Gogus Kalp Damar Cerrahisi Derg ; 30(4): 611-621, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36605322

ABSTRACT

Background: This study aims to evaluate humoral immune system response by measuring copy numbers of kappa-deleting recombination excision circles (KREC) gene segment from B lymphocytes in patients with lung transplantation. Methods: Between September 2015 and November 2016, a total of 11 patients (8 males, 3 females; mean age: 45.4±12.0 years; range, 23 to 59 years) who underwent lung transplantation with different primary indications were included. The copy numbers of KREC gene segment were quantified using real-time polymerase chain reaction method in peripheral blood samples collected pre- and post-transplantation. The samples of the patients were compared with the KREC l evels i n deoxyribonucleic acid extracted from blood samples of healthy children. Results: There was no significant change in KREC levels between pre- and post-operation (p=0.594 and p=0.657), although the median values indicated that the highest increase in the KREC levels (7x105- 12x105; 85-170) was on Day 7 of transplantation. There was a positive correlation between the KREC levels (mL in blood) and lymphocytes at 24 h after transplantation (p=0.043) and between KREC copies per 106 of blood and age on Day 7. Conclusion: Our preliminary results suggest that KREC l evels a s an indicator of B lymphocyte production are elevated after lung transplantation. A prognostic algorithm by tracking B cell kinetics after post-transplantation for long-term follow-up can be developed following the confirmation of these preliminary results with more patient samples.

6.
Gen Thorac Cardiovasc Surg ; 69(3): 577-579, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32997235

ABSTRACT

Here, we report a 54-year-old man who underwent double-sleeve left upper lobectomy for lung cancer and his postoperative course was complicated with COVID-19 pneumonia. Five days after his discharge from hospital, he was re-admitted with mild fever and bilateral multiple ground glass opacities on his chest CT. PCR testing confirmed COVID-19 infection and he was treated according to policies established by our nation's health authority. He is still receiving adjuvant chemotherapy and remains well at 3 months after the operation.


Subject(s)
COVID-19/etiology , Lung Neoplasms/surgery , Pneumonectomy/adverse effects , Pneumonia, Viral/etiology , RNA, Viral/analysis , SARS-CoV-2/genetics , COVID-19/epidemiology , Humans , Male , Middle Aged , Pneumonia, Viral/diagnosis , Pneumonia, Viral/virology , Tomography, X-Ray Computed
7.
Braz J Cardiovasc Surg ; 33(5): 483-489, 2018.
Article in English | MEDLINE | ID: mdl-30517257

ABSTRACT

INTRODUCTION: Optimal surgical approach for the treatment of resectable lung cancer accompanied by coronary artery disease (CAD) remains a contentious issue. In this study, we present our cases that were operated simultaneously for concurrent lung cancer and CAD. METHODS: Simultaneous off-pump coronary artery bypass surgery (OPCABG) and lung resection were performed on 10 patients in our clinic due to lung cancer accompanied by CAD. Demographic features of patients, operation data and postoperative results were evaluated retrospectively. RESULTS: Mean patient age was 63.3 years (range 55-74). All patients were male. Six cases of squamous cell carcinoma, three of adenocarcinoma and one case of large cell carcinoma were diagnosed. Six patients had single-vessel CAD and 4 had two-vessel CAD. Three patients underwent OPCABG at first and then lung resection. The types of resections were one right pneumonectomy, three right upper lobectomies, one right lower lobectomy, three left upper lobectomies, and two left lower lobectomies. Reoperation was performed in one patient due to hemorrhage. One patient developed intraoperative contralateral tension pneumothorax. One patient died due to acute respiratory distress syndrome at the early postoperative period. CONCLUSION: Simultaneous surgery is a safe and reliable option in the treatment of selected patients with concurrent CAD and operable lung cancer.


Subject(s)
Coronary Artery Bypass, Off-Pump , Coronary Artery Disease/surgery , Lung Neoplasms/surgery , Pneumonectomy , Aged , Coronary Artery Disease/complications , Humans , Length of Stay , Lung Neoplasms/complications , Male , Middle Aged , Retrospective Studies , Treatment Outcome
8.
Rev. bras. cir. cardiovasc ; 33(5): 483-489, Sept.-Oct. 2018. tab
Article in English | LILACS | ID: biblio-977450

ABSTRACT

Abstract Introduction: Optimal surgical approach for the treatment of resectable lung cancer accompanied by coronary artery disease (CAD) remains a contentious issue. In this study, we present our cases that were operated simultaneously for concurrent lung cancer and CAD. Methods: Simultaneous off-pump coronary artery bypass surgery (OPCABG) and lung resection were performed on 10 patients in our clinic due to lung cancer accompanied by CAD. Demographic features of patients, operation data and postoperative results were evaluated retrospectively. Results: Mean patient age was 63.3 years (range 55-74). All patients were male. Six cases of squamous cell carcinoma, three of adenocarcinoma and one case of large cell carcinoma were diagnosed. Six patients had single-vessel CAD and 4 had two-vessel CAD. Three patients underwent OPCABG at first and then lung resection. The types of resections were one right pneumonectomy, three right upper lobectomies, one right lower lobectomy, three left upper lobectomies, and two left lower lobectomies. Reoperation was performed in one patient due to hemorrhage. One patient developed intraoperative contralateral tension pneumothorax. One patient died due to acute respiratory distress syndrome at the early postoperative period. Conclusion: Simultaneous surgery is a safe and reliable option in the treatment of selected patients with concurrent CAD and operable lung cancer.


Subject(s)
Humans , Male , Middle Aged , Aged , Pneumonectomy , Coronary Artery Disease/surgery , Coronary Artery Bypass, Off-Pump , Lung Neoplasms/surgery , Coronary Artery Disease/complications , Retrospective Studies , Treatment Outcome , Length of Stay , Lung Neoplasms/complications
9.
Interact Cardiovasc Thorac Surg ; 19(4): 650-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24994700

ABSTRACT

OBJECTIVES: Owing to the great absorption capability of the pleura for transudates, the protein content of draining pleural fluid may be considered as a more adequate determinant than its daily draining amount in the decision-making for earlier chest tube removal. In an a priori pilot study, we observed that the initially draining protein-rich exudate converts to a transudate quickly in most patients after lobectomies. Thus, chest tubes draining high-volume but low-protein fluids can safely be removed earlier in the absence of an air leak. This randomized study aims to investigate the validity and clinical applicability of this hypothesis as well as its influence on the timing for chest tube removal and earlier discharge after lobectomy. METHODS: Seventy-two consecutive patients undergoing straightforward lobectomy were randomized into two groups. Patients with conditions affecting postoperative drainage and with persisting air leaks beyond the third postoperative day were excluded. Drains were removed if the pleural fluid to blood protein ratio (PrRPl/B) was ≤0.5, regardless of its daily draining amount in the study arm (Group S; n = 38), and patients in the control arm (Group C; n = 34) had their tubes removed if daily drainage was ≤250 ml regardless of its protein content. Patients were discharged home immediately or the following morning after removal of the last drain. All cases were followed up regarding the development of symptomatic pleural effusions and hospital readmissions for a redrainage procedure. RESULTS: Demographic and clinical characteristics as well as the pattern of decrease in PrRPl/B were the same between groups. The mean PrRPl/B was 0.65 and 0.67 (95% CI = 0.60-0.69 and 0.62-0.72) on the first postoperative day, and it remarkably dropped down to 0.39 and 0.33 (95% CI = 0.33-0.45 and 0.27-0.39) on the second day in Groups S and C, respectively, and remained below 0.5 on the third day (repeated-measures of ANOVA design, post hoc 'within-group' comparison of the first postoperative day versus second and third days; P < 0.002). Eleven of 38 (29%) and 16 of 27 (59%) patients' chest tubes were, respectively, removed on the first and second postoperative days in Group S, but only two of 34 (6%) and ten of 32 (31%) patients, respectively, had their chest tubes removed in Group C (two-tailed Fisher's exact test, P = 0.02 and 0.005 for the first and the second postoperative days, respectively). On the third postoperative day, daily drainage remained ≥250 ml in 22 (65%) patients, among whom, 17 (77%) would have their chest tubes removed on the PrRPl/B value in Group C. However, drains could not be removed due to the high protein content of draining fluid despite the acceptable volume of daily drainage in only three (27%) of 11 cases in Group S (McNemar's paired proportions test, P = 0.009). The mean chest tube removal time (2.1 ± 0.9 vs 2.9 ± 1.0 days; P < 0.001) and the median hospital stay [3 days (IQR: 1-3) vs 4 days (IQR: 2-4), P < 0.003] were significantly shorter in Group S. None of the patients required a redrainage procedure due to a persistent and symptomatic pleural effusion. CONCLUSIONS: Regardless of the daily drainage, chest tubes can safely be removed earlier than anticipated in most patients after lobectomy if the protein content of the draining fluid is low.


Subject(s)
Blood Proteins/metabolism , Chest Tubes , Device Removal , Drainage/instrumentation , Exudates and Transudates/metabolism , Intubation, Intratracheal/instrumentation , Pleural Effusion/therapy , Pneumonectomy/adverse effects , Adult , Aged , Biomarkers/metabolism , Female , Humans , Male , Middle Aged , Pleural Effusion/diagnosis , Pleural Effusion/etiology , Pleural Effusion/metabolism , Predictive Value of Tests , Prospective Studies , Time Factors , Treatment Outcome , Turkey
10.
Anadolu Kardiyol Derg ; 10 Suppl 2: 39-41, 2010 Sep.
Article in Turkish | MEDLINE | ID: mdl-20819755

ABSTRACT

Pulmonary hypertension is one of the indications for lung transplantation. Recent advances on medical management of the disease have dramatically decreased the number of patients who required lung transplantation. In reported series, single or double lung transplantation have been successfully undertaken by many transplant centers. In patients, whose cardiac functions are irreversibly damaged heart-lung transplantation remains as an only option for long term survival. Transplantation should only be considered in those patients who are having optimal medical support and relatively good condition for a major operation.


Subject(s)
Hypertension, Pulmonary/surgery , Lung Transplantation , Patient Selection , Heart Transplantation , Humans , Treatment Outcome
11.
Interact Cardiovasc Thorac Surg ; 10(5): 830-2, 2010 May.
Article in English | MEDLINE | ID: mdl-20123891

ABSTRACT

Lung volume reduction surgery (LVRS) is one of the surgical options in the treatment of advanced emphysema and may also be considered as a 'bridge' operation to lung transplantation in selected patients. Although its long-term effects are still debatable, some patients significantly benefit from this operation. Secondary spontaneous pneumothorax is one of the commonest complications of severe emphysema that necessitates an emergency drainage procedure. However, there is no satisfactory information regarding the management of this complication occurring after LVRS in the literature. This paper reports a case of bilateral pneumothorax three months after a unilateral LVRS that was performed following a contra-lateral talc pleurodesis for recurrent pneumothorax.


Subject(s)
Pleurodesis/adverse effects , Pneumonectomy/adverse effects , Pneumothorax/etiology , Pneumothorax/surgery , Pulmonary Emphysema/therapy , Follow-Up Studies , Humans , Male , Middle Aged , Pleurodesis/methods , Pneumonectomy/methods , Pneumothorax/diagnostic imaging , Postoperative Care/methods , Pulmonary Emphysema/diagnostic imaging , Radiography, Thoracic , Recurrence , Reoperation , Respiratory Function Tests , Risk Assessment , Severity of Illness Index , Talc/pharmacology , Thoracic Surgery, Video-Assisted/adverse effects , Thoracic Surgery, Video-Assisted/methods , Thoracostomy/methods , Tomography, X-Ray Computed , Treatment Outcome
12.
Interact Cardiovasc Thorac Surg ; 10(2): 200-3, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19933240

ABSTRACT

Integrated positron emission tomography and computed tomography (PET/CT) scanning has become the standard for oncologic imaging. We sought to determine the role of PET/CT in mediastinal non-small cell lung cancer staging. One hundred and twenty-seven consecutive patients were enrolled in the study where PET/CT was performed due to pathologically defined non-small cell carcinoma from a single center. They all underwent complete resection with a thoracotomy and systemic lymph node dissection (SLND) between October 2005 and January 2007. Postoperative pathology results of lymph node stations regarding the nodal spread and stage were compared with clinical stage obtained by PET/CT. The sensitivity, specificity, accuracy, negative predictive value (NPV) and positive predictive value (PPV) of PET/CT in N2 cases were determined to be 72.0%, 94.4%, 92.7%, 97.7% and 49.2%, respectively. Maximum standard uptake (SUV(max)) cut-off value for mediastinal N2 involvement in PET/CT was obtained by applying 'receiver operating characteristic' (ROC) analysis that was set to 5.2. Correct stage with PET/CT was established in 76.3% of cases. Staging of non-small cell lung cancer (NSCLC), according to the PET/CT for which we determined 97.79% NPV, we consider that thoracotomy without preoperative mediastinal invasive staging in cases of negative mediastinal involvement in PET/CT can be certainly performed.


Subject(s)
Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Lung Neoplasms/diagnostic imaging , Positron-Emission Tomography , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma, Non-Small-Cell Lung/secondary , Carcinoma, Non-Small-Cell Lung/surgery , False Positive Reactions , Female , Humans , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Lymph Node Excision , Lymphatic Metastasis , Male , Mediastinoscopy , Middle Aged , Neoplasm Staging , Predictive Value of Tests , ROC Curve , Sensitivity and Specificity , Thoracotomy
13.
Ann Thorac Surg ; 87(4): 1274-5, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19324171

ABSTRACT

We present a rare case of malignant invasive thymoma (type A) arising from the posterior mediastinum. A 17-year-old girl was referred to our clinic after detection of a mass on a chest roentgenogram. Thoracoscopy showed a lobulated, pale yellowish mass located in the posterior compartment together with several foci in the lung parenchyma. The tumor and parenchymal foci were totally resected through a left minithoracotomy. Postoperative pathology revealed malignant invasive thymoma type A.


Subject(s)
Thymoma/therapy , Thymus Neoplasms/therapy , Adolescent , Female , Humans , Mediastinum , Thoracic Surgery, Video-Assisted
16.
Heart Lung Circ ; 18(4): 299-301, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18514025

ABSTRACT

In this paper, we present 3 patients who had previously undergone pneumonectomy and then presented with a spontaneous pneumothorax. The indication for pneumonectomy was tuberculosis and NSCLC in 2 and 1 patient, respectively. The interval between the surgery and development of pneumothorax was 2, 4, and 11 years. On admission, 2 of the 3 patients were in extreme respiratory distress requiring urgent chest tube insertion. In all patients we undertook elective video-assisted thoracoscopy with complete preparation for cardiopulmonary support on the side. Bullectomy and/or diathermy ablation for apical bullae and blebs were performed concomitantly with total parietal pleurectomy. The postoperative course was uneventful in the patients, and they remain on routine follow-up for up to 6-12 months without any complaints. Our experience suggests that emphysematous changes in the remaining lung should be carefully inspected during long-term follow-up after pneumonectomy. Video-assisted thoracoscopic (VAT) pleurectomy appears to be a good option for the management of spontaneous pneumothorax only if it is performed by a dedicated multidisciplinary team with various cardiopulmonary support facilities on the side.


Subject(s)
Pleura/surgery , Pneumonectomy/adverse effects , Pneumothorax/surgery , Thoracic Surgery, Video-Assisted , Thoracoscopy , Adult , Female , Humans , Male , Middle Aged , Pneumothorax/etiology
20.
Ann Thorac Surg ; 85(1): 333-4, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18154842

ABSTRACT

A 55-year-old woman was referred to our department with the diagnosis of a bronchopleural fistula and empyema. Her medical history revealed that she had undergone a left pneumonectomy 25 years prior due to a destroyed lung associated with tuberculosis. Open drainage and a biopsy was performed because of the large mass detected on thoracic computed tomography. Postoperative pathology revealed squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/pathology , Cicatrix, Hypertrophic/pathology , Lung Neoplasms/pathology , Pneumonectomy/adverse effects , Biopsy, Needle , Carcinoma, Squamous Cell/surgery , Disease Progression , Fatal Outcome , Female , Humans , Immunohistochemistry , Lung Neoplasms/surgery , Middle Aged , Pneumonectomy/methods , Reoperation , Tomography, X-Ray Computed , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...